A review of signal transduction in mechanisms of smooth muscle contraction and its relevance for specialized physical therapy

Journal of Physical Therapy Science

Volumn 25, Issue 1, 2013, Pages 129-141

  Kim, Ju Hyun ^a   Lee, Lim Kyu ^a   Lee, Won Deok ^a   Lee, Jeong Uk ^a   Kim, Mee Young ^a   Kim, Il Hyun ^a   Choi, Bo Ra ^a   Yang, Seung Min ^a   Jeon, Hye Joo ^a   Lee, Tae Hyun ^a   Kwak, Taek Yong ^a   Kim, Bokyung ^b   Kim, Junghwan ^a  

^a Yongin University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

Physical therapy; Signal transduction; Smooth muscle contraction

Indexed keywords

EID: 84874399855     PISSN: 09155287     EISSN: None     Source Type: Journal    
DOI: 10.1589/jpts.25.129     Document Type: Review

References (115)

1. 2+localization and sensitivity in vascular smooth muscle. Trends Pharmacol Sci, 1989, 10: 320-325. [Medline] [CrossRef]
2. Karaki H, Ozaki H, Hori M, et al.: Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev, 1997, 49: 157-230. [Medline]
3. 2+and contraction in vascular smooth muscle. Eur J Pharmacol, 1992, 223: 157-162. [Medline] [CrossRef]
4. 2+level and contraction in rat myometrium after gestation. Jpn J Pharmacol, 1996, 72: 111-118. [Medline] [CrossRef]
5. Kim BK, Ozaki H, Lee SM, et al.: Increased sensitivity of rat myometrium to the contractile effect of platelet activating factor before delivery. Br J Pharmacol, 1995, 115: 1211-1214. [Medline] [CrossRef]
6. Kim B, Kim YS, Ahn J, et al.: Conventional-type protein kinase C contributes to phorbol ester-induced inhibition of rat myometrial tension. Br J Pharmacol, 2003, 139: 408-414. [Medline] [CrossRef]
7. Kim B, Kim J, Kim A, et al.: Ligusticum wallichi-induced vasorelaxation mediated by mitogen-activated protein kinase in rat aortic smooth muscle. J Ethnopharmacol, 2004a, 90: 397-401. [Medline] [CrossRef]
8. Kim B, Kim J, Bae YM, et al.: p38 Mitogen-activated protein kinase contributes to diminished aortic contraction by endothelin-1 in DOCA-salt hypertensive rats. Hypertension, 2004b, 43: 1086-1091. [CrossRef]
9. Kim J, Lee YR, Lee CH, et al.: Mitogen-activated protein kinase contributes to elevated basal tone in aortic smooth muscle from hypertensive rats. Eur J Pharmacol, 2005, 514: 209-215. [Medline] [CrossRef]
10. Kim J, Lee CK, Park HJ, et al.: Epidermal growth factor induces vasoconstriction through the phosphatidylinositol 3-kinase-mediated mitogenactivated protein kinase pathway in hypertensive rats. J Pharmacol Sci, 2006, 101: 135-143. [Medline] [CrossRef]
11. Lee HM, Won KJ, Kim J, et al.: Endothelin-1 induces contraction via a Syk-mediated p38 mitogen-activated protein kinase pathway in rat aortic smooth muscle. J Pharmacol Sci, 2007, 103: 427-433. [Medline] [CrossRef]
12. Lee CK, Han JS, Won KJ, et al.: Diminished expression of dihydropteridine reductase is a potent biomarker for hypertensive vessels. Proteomics, 2009, 9: 4851-4858. [Medline] [CrossRef]
13. Won KJ, Lee SC, Lee CK, et al.: Cordycepin attenuates neointimal formation by inhibiting reactive oxygen species-mediated responses in vascular smooth muscle cells in rats. J Pharmacol Sci, 2009, 109: 403-412. [Medline] [CrossRef]
14. Won KJ, Lee P, Jung SH, et al.: 3-morpholinosydnonimine participates in the attenuation of neointima formation via inhibition of annexin A2-mediated vascular smooth muscle cell migration. Proteomics, 2011, 11: 193-201. [Medline] [CrossRef]
15. Chon KY, Kim IS, Choi KY, et al.: The noxiousness of the salt-dependent hypertension and the effect of the physical stimulation on the change of the hypertension-related sympathetic Neurotransmitter; a study on the utilization of physical therapy facilities in senior welfare center. J Korean Gerontol Soc, 2004, 24: 1-11.
16. Kim JH, Kim J: The effects of physical therapy on activation of sympathetic nerve system among older adults participating to welfare centers for the elderly. J Korean Gerontol Soc, 2010, 30: 311-322.
17. Kim JH, Kim IH, Lee JU: Noxiousness of hypertension-related norepinephrine and upregulation of norepinephrine by high intensity of electrical stimulation in healthy volunteers. J Phys Ther Sci, 2012, 24: (in press).
18. Kim BK, Ozaki H, Hori M, et al.: Increased contractility of rat uterine smooth muscle at the end of pregnancy. Comp Biochem Physiol A Mol Integr Physiol, 1998, 121: 165-173. [Medline] [CrossRef]
19. Somlyo AP, Wu X, Walker LA, et al.: Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol, 1999, 134: 201-234. [Medline]
20. Sobue K, Muramoto Y, Fujita M, et al.: Purification of a calmodulinbinding protein from chicken gizzard that interacts with F-actin. Proc Natl Acad Sci USA, 1981, 78: 5652-5655. [Medline] [CrossRef]
21. Sobue K, Kanda K, Tanaka T, et al.: Caldesmon: a common actin-linked regulatory protein in the smooth muscle and nonmuscle contractile system. J Cell Biochem, 1988, 37: 317-325. [Medline] [CrossRef]
22. Bitar KN: HSP27 phosphorylation and interaction with actin-myosin in smooth muscle contraction. Am J Physiol Gastrointest Liver Physiol, 2002, 282: G894-G903. [Medline]
23. Hartshorne DJ, Siemankowski RF: Regulation of smooth muscle actomyosin. Annu Rev Physiol, 1981, 43: 519-530. [Medline] [CrossRef]
24. Berridge MJ: The Albert Lasker Medical Awards. Inositol trisphosphate, calcium, lithium, and cell signaling. JAMA, 1989, 262: 1834-1841. [Medline] [CrossRef]
25. Iino M: Calcium release mechanisms in smooth muscle. Jpn J Pharmacol, 1990, 54: 345-354. [Medline] [CrossRef]
26. 2+-sensitive ion channels. Cell Calcium, 2003, 34: 211-229. [Medline] [CrossRef]
27. Karaki H, Weiss GB: Calcium channels in smooth muscle. Gastroenterology, 1984, 87: 960-970. [Medline]
28. Nishizuka Y: The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature, 1984, 308: 693-698. [Medline] [CrossRef]
29. Nishizuka Y: Studies and perspectives of protein kinase C. Science, 1986, 233: 305-312. [Medline] [CrossRef]
30. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science, 1992, 258: 607-614. [Medline] [CrossRef]
31. Newton AC: Protein kinase C: structure, function, and regulation. J Biol Chem, 1995, 270: 28495-28498. [Medline]
32. Hayashi A, Seki N, Hattori A, et al.: PKCν, a new member of the protein kinase C family, composes a fourth subfamily with PKCμ. Biochim Biophys Acta, 1999, 1450: 99-106. [Medline] [CrossRef]
33. Ron D, Kazanietz MG: New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J, 1999, 13: 1658-1676. [Medline]
34. Mellor H, Parker PJ: The extended protein kinase C superfamily. Biochem J, 1998, 332: 281-292. [Medline]
35. Quest AF, Bloomenthal J, Bardes ES, et al.: The regulatory domain of protein kinase C coordinates four atoms of zinc. J Biol Chem, 1992, 267: 10193-10197. [Medline]
36. 2+-independent protein kinase Cs contain an amino-terminal domain similar to the C2 consensus sequence. Trends Biochem Sci, 1993, 18: 207-208. [Medline] [CrossRef]
37. Ponting CP, Parker PJ: Extending the C2 domain family: C2s in PKCs δ, ε, η, θ, phospholipases, GAPs, and perforin. Protein Sci, 1996, 5: 162-166. [Medline] [CrossRef]
38. Idris I, Gray S, Donnelly R: Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia, 2001, 44: 659-673. [Medline] [CrossRef]
39. Berridge MJ: Inositol trisphosphate and calcium signalling. Nature, 1993, 361: 315-325. [Medline] [CrossRef]
40. Newton AC: Interaction of proteins with lipid headgroups: lessons from protein kinase C. Annu Rev Biophys Biomol Struct, 1993, 22: 1-25. [Medline] [CrossRef]
41. Davidson FM, Long C: The structure of the naturally occurring phosphoglycerides. Action of cabbage-leaf phospholipase D on ovolecithin and related substances. Biochem J, 1958, 69: 458-466. [Medline]
42. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J, 1995, 9: 484-496. [Medline]
43. Galizzi JP, Qar J, Fosset M, et al.: Regulation of calcium channels in aortic muscle cells by protein kinase C activators (diacylglycerol and phorbol esters) and by peptides (vasopressin and bombesin) that stimulate phosphoinositide breakdown. J Biol Chem, 1987, 262: 6947-6950. [Medline]
44. 2+-independent contraction in vascular smooth muscle. Am J Physiol, 1996, 271: C589-C594. [Medline]
45. i-2activation of Rho. Am J Physiol, 1999, 277: L653-L661. [Medline]
46. Gosser YQ, Nomanbhoy TK, Aghazadeh B, et al.: C-terminal binding domain of Rho GDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases. Nature, 1997, 387: 814-819. [Medline] [CrossRef]
47. Fujihara H, Walker LA, Gong MC, et al.: Inhibition of RhoA translocation and calcium sensitization by in vivo ADP-ribosylation with the chimeric toxin DC3B. Mol Biol Cell, 1997, 8: 2437-2447. [Medline]
48. Swärd K, Mita M, Wilson DP, et al.: The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction. Curr Hypertens Rep, 2003, 5: 66-72. [Medline] [CrossRef]
49. Herskowitz I: MAP kinase pathways in yeast: for mating and more. Cell, 1995, 80: 187-197. [Medline] [CrossRef]
50. Pelech SL, Sanghera JS: Mitogen-activated protein kinases: versatile transducers for cell signaling. Trends Biochem Sci, 1992, 17: 233-238. [Medline] [CrossRef]
51. Takahashi E, Berk BC: MAP kinases and vascular smooth muscle function. Acta Physiol Scand, 1998, 164: 611-621. [Medline]
52. Kyriakis JM, Avruch J: Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev, 2001, 81: 807-869. [Medline]
53. Muda M, Boschert U, Dickinson R, et al.: MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogenactivated protein kinase phosphatase. J Biol Chem, 1996, 271: 4319-4326. [Medline] [CrossRef]
54. Minshull J, Sun H, Tonks NK, et al.: A MAP kinase-dependent spindle assembly checkpoint in Xenopus egg extracts. Cell, 1994, 79: 475-486. [Medline] [CrossRef]
55. Tokuda H, Hirade K, Wang X, et al.: Involvement of SAPK/JNK in basic fibroblast growth factor-induced vascular endothelial growth factor release in osteoblasts. J Endocrinol, 2003, 177: 101-107. [Medline] [CrossRef]
56. Tournier C, Whitmarsh AJ, Cavanagh J, et al.: Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase. Proc Natl Acad Sci USA, 1997, 94: 7337-7342. [Medline] [CrossRef]
57. Garrington TP, Johnson GL: Organization and regulation of mitogenactivated protein kinase signaling pathways. Curr Opin Cell Biol, 1999, 11: 211-218. [Medline] [CrossRef]
58. Hori M, Karaki H: Regulatory mechanisms of calcium sensitization of contractile elements in smooth muscle. Life Sci, 1998, 62: 1629-1633. [Medline] [CrossRef]
59. Ueki N, Sobue K, Kanda K, et al.: Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA, 1987, 84: 9049-9053. [Medline] [CrossRef]
60. Graceffa P, Wang CL, Stafford WF: Caldesmon. Molecular weight and subunit composition by analytical ultracentrifugation. J Biol Chem, 1988, 263: 14196-14202. [Medline]
61. Gerthoffer WT, Yamboliev IA, Shearer M, et al.: Activation of MAP kinases and phosphorylation of caldesmon in canine colonic smooth muscle. J Physiol, 1996, 495: 597-609. [Medline]
62. Tanaka T, Ohta H, Kanda K, et al.: Phosphorylation of high-Mr caldesmon by protein kinase C modulates the regulatory function of this protein on the interaction between actin and myosin. Eur J Biochem, 1990, 188: 495-500. [Medline] [CrossRef]
63. Chalovich JM, Sen A, Resetar A, et al.: Caldesmon: binding to actin and myosin and effects on elementary steps in the ATPase cycle. Acta Physiol Scand, 1998, 164: 427-435. [Medline] [CrossRef]
64. Yanagisawa M, Kurihara H, Kimura S, et al.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 1988, 332: 411-415. [Medline] [CrossRef]
65. Inoue A, Yanagisawa M, Kimura S, et al.: The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA, 1989a, 86: 2863-2867. [Medline] [CrossRef]
66. Masaki T: Historical review: endothelin. Trends Pharmacol Sci, 2004, 25: 219-224. [Medline] [CrossRef]
67. Arinami T, Ishikawa M, Inoue A, et al.: Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23-p24, the endothelin-2 gene (EDN2) to 1p34, and the endothelin-3 gene (EDN3) to 20q13.2-q13.3. Am J Hum Genet, 1991, 48: 990-996. [Medline]
68. Jośko J, Hendryk S, Jedrzejowska-Szypulka H, et al.: Effect of endothelin-1 receptor antagonist BQ-123 on basilar artery diameter after subarachnoid hemorrhage (SAH) in rats. J Physiol Pharmacol, 2000, 51: 241-249. [Medline]
69. Goraca A: New views on the role of endothelin. Endocr Regul, 2002, 36: 161-167. [Medline]
70. Inoue A, Yanagisawa M, Takuwa Y, et al.: The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J Biol Chem, 1989b, 264: 14954-14959. [Medline]
71. Xu D, Emoto N, Giaid A, et al.: ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell, 1994, 78: 473-485. [Medline] [CrossRef]
72. Emoto N, Yanagisawa M: Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem, 1995, 270: 15262-15268. [Medline] [CrossRef]
73. Dashwood MR, Tsui JC: Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade. Atherosclerosis, 2002, 160: 297-304. [Medline] [CrossRef]
74. Ortega Mateo A, de Artiñano AA: Highlights on endothelins: a review. Pharmacol Res, 1997, 36: 339-351. [Medline] [CrossRef]
75. Haynes WG, Webb DJ: Endothelin as a regulator of cardiovascular function in health and disease. J Hypertens, 1998, 16: 1081-1098. [Medline] [CrossRef]
76. Morise T, Takeuchi Y, Kawano M, et al.: Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients. Diabetes Care, 1995, 18: 87-89. [Medline] [CrossRef]
77. Sumner MJ, Cannon TR, Mundin JW, et al.: Endothelin ETA a nd E TB receptors mediate vascular smooth muscle contraction. Br J Pharmacol, 1992, 107: 858-860. [Medline] [CrossRef]
78. Attinà T, Camidge R, Newby DE, et al.: Endothelin antagonism in pulmonary hypertension, heart failure, and beyond. Heart, 2005, 91: 825-831. [Medline] [CrossRef]
79. Arai H, Nakao K, Takaya K, et al.: The human endothelin-B receptor gene. Structural organization and chromosomal assignment. J Biol Chem, 1993, 268: 3463-3470. [Medline]
80. Hosoda K, Nakao K, Arai H, et al.: Cloning and expression of human endothelin-1 receptor cDNA. FEBS Lett, 1991, 287: 23-26. [Medline] [CrossRef]
81. Haynes WG, Strahan FE, Webb DJ: Endothelin ETA a nd E TB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation, 1995, 92: 357-363. [Medline] [CrossRef]
82. Liu J, Chen R, Casley DJ, et al.: Ischemia and reperfusion increase 125I-labeled endothelin-1 binding in rat cardiac membranes. Am J Physiol, 1990, 258: H829-H835. [Medline]
83. Inui T, Ninomiya H, Sasaki Y, et al.: Selective activation of excitationcontraction coupling pathways by ETA a nd E TB receptors in guinea-pig tracheal smooth muscle. Br J Pharmacol, 1999, 126: 893-902. [Medline] [CrossRef]
84. 2+channels in endothelin-1 function. Cell Signal, 2005, 17: 911-916. [Medline] [CrossRef]
85. 2+channels involved in endothelin-1-induced contraction of rabbit basilar artery. J Cardiovasc Pharmacol, 2002a, 40: 438-447. [Medline] [CrossRef]
86. Kawanabe Y, Okamoto Y, Nozaki K, et al.: Molecular mechanism for endothelin-1-induced stress-fiber formation: analysis of G proteins using a mutant endothelin (A) receptor. Mol Pharmacol, 2002b, 61: 277-284. [Medline] [CrossRef]
87. Kelso EJ, McDermott BJ, Silke B, et al.: Endothelin A receptor subtype mediates endothelin-induced contractility in left ventricular cardiomyocytes isolated from rabbit myocardium. J Pharmacol Exp Ther, 2000, 294: 1047-1052. [Medline]
88. 2+release from sarcoplasmic reticulum in smooth muscle. Biochem Biophys Res Commun, 1987, 144: 1313-1316. [Medline] [CrossRef]
89. 2+channels in endothelin-1-induced MAP kinase phosphorylation, myosin light chain phosphorylation and contraction in rabbit iris sphincter smooth muscle. Cell Signal, 2004, 16: 609-619. [Medline] [CrossRef]
90. Yanagi S, Kurosaki T, Yamamura H: The structure and function of nonreceptor tyrosine kinase p72SYK expressed in hematopoietic cells. Cell Signal, 1995, 7: 185-193. [Medline] [CrossRef]
91. Lee HM, Kim HJ, Won KJ, et al.: Contribution of soluble intercellular adhesion molecule-1 to the migration of vascular smooth muscle cells. Eur J Pharmacol, 2008a, 579: 260-268. [Medline] [CrossRef]
92. Lee HM, Kim HJ, Won KJ, et al.: Soluble form of vascular cell adhesion molecule 1 induces migration and proliferation of vascular smooth muscle cells. J Vasc Res, 2008b, 45: 259-268. [Medline] [CrossRef]
93. Martin J, Horwich AL, Hartl FU: Prevention of protein denaturation under heat stress by the chaperonin Hap60. Science, 1992, 258: 995-998. [Medline] [CrossRef]
94. Ritossa F: Discovery of the heat shock response. Cell Stress Chaperones, 1996, 1: 97-98. [Medline] [CrossRef]
95. Lindquist S: Heat-shock proteins and stress tolerance in microorganisms. Curr Opin Genet Dev, 1992, 2: 748-755. [Medline] [CrossRef]
96. Tytell M, Barbe MF, Brown IR: Induction of Heat shock (stress) protein 70 and its mRNA in the normal and light-damaged rat retina after whole body hyperthermia. J Neurosci Res, 1994, 38: 19-31. [Medline] [CrossRef]
97. Lindquist S, Craig EA: The heat-shock proteins. Annu Rev Genet, 1988, 22: 631-677. [Medline] [CrossRef]
98. Nieto-Sotelo J, Wiederrecht G, Okuda A, et al.: The yeast heat shock transcription factor contains a transcriptional activation domain whose activity is repressed under nonshock conditions. Cell, 1990, 62: 807-817. [Medline] [CrossRef]
99. Morimoto RI, Sarge KD, Abravaya K: Transcriptional regulation of heat shock genes. J Biol Chem, 1992, 267: 21987-21990. [Medline]
100. Ciocca DR, Oesterreich S, Chamness GC, et al.: Biological and clinical implications of heat shock protein 27000 (Hsp27): a review. J Natl Cancer Inst, 1993, 85: 1558-1570. [Medline] [CrossRef]
101. Rabindran SK, Haroun RI, Clos J, et al.: Regulation of heat shock factor trimer formation: role of a conserved leucine zipper. Science, 1993, 259: 230-234. [Medline] [CrossRef]
102. Sorger PK, Nelson HC: Trimerization of a yeast transcriptional activator via a coiled-coil motif. Cell, 1989, 59: 807-813. [Medline] [CrossRef]
103. Sorger PK: Heat shock factor and the heat shock response. Cell, 1991, 65: 363-366. [Medline] [CrossRef]
104. Jakobsen BK, Pelham HR: A conserved heptapeptide restrains the activity of the yeast heat shock transcription factor. EMBO J, 1991, 10: 369-375. [Medline]
105. Isomoto H, Ohtsuru A, Braiden V, et al.: Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer. Oncol Rep, 2006, 15: 629-635. [Medline]
106. Batulan Z, Taylor DM, Aarons RJ, et al.: Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis. Neurobiol Dis, 2006, 24: 213-225. [Medline] [CrossRef]
107. Wang XR, Xiao J, Sun DJ: Myocardial protective effects of electroacupuncture and hypothermia on porcine heart after ischemia/reperfusion. Acupunct Electrother Res, 2003, 28: 193-200. [Medline]
108. Kobayashi K: Induction of heat-shock protein (hsp) by moxibustion. Am J Chin Med, 1995, 23: 327-330. [Medline] [CrossRef]
109. Su F, Nguyen ND, Wang Z, et al.: Fever control in septic shock: beneficial or harmful? Shock, 2005, 23: 516-520. [Medline]
110. Tedeschi B, Ciavarra RP: Differential effects of axotomy on the in vivo synthesis of the stress-inducible and constitutive 70-kDa heat-shock proteins in rat dorsal root ganglia. Brain Res Mol Brain Res, 1997, 45: 199-206. [Medline] [CrossRef]
111. Dhillon VB, McCallum S, Norton P, et al.: Differential heat shock protein overexpression and its clinical relevance in systemic lupus erythematosus. Ann Rheum Dis, 1993, 52: 436-442. [Medline] [CrossRef]
112. Tabibzadeh S, Kong QF, Satyaswaroop PG, et al.: Heat shock proteins in human endometrium throughout the menstrual cycle. Hum Reprod, 1996, 11: 633-640. [Medline] [CrossRef]
113. Miller P, Smith DW, Shepard TH: Maternal hyperthermia as a possible cause of anencephaly. Lancet, 1978, 1: 519-521. [Medline] [CrossRef]
114. Coffey VP, Jessop WJ: Maternal influenza and congenital deformities. Lancet, 1959, 2: 935-938. [Medline] [CrossRef]
115. Yi SX, Yang RD, Yan J, et al.: Effect of electro-acupuncture at footyangming meridian on somatostatin and expression of somatostatin receptor genes in rabbits with gastric ulcer. World J Gastroenterol, 2006, 12: 1761-1765. [Medline]